Annuloplasty System Market Size, Share & Trends Analysis Report By Application (Mitral Valve Repair, Tricuspid Valve Repair), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030

Annuloplasty System Market Size, Share & Trends Analysis Report By Application (Mitral Valve Repair, Tricuspid Valve Repair), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030

Annuloplasty System Market Size & Trends

The global annuloplasty system market size was estimated at USD 447.8 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2030. The increasing prevalence of cardiovascular diseases (CVD) is one of the aspects that drive the market's growth. According to the American College of Cardiology Foundation article published in December 2023, the rising global burden of cardiovascular disease (CVD), with deaths increasing from 12.4 million in 1990 to 19.8 million in 2022, highlights a growing need for effective cardiac interventions.

Population growth, aging, and preventable metabolic, environmental, and behavioral risks have all contributed to this surge. Valve-related disorders, a significant subset of CVD, are increasingly prevalent, driving the demand for advanced solutions like annuloplasty systems. These systems are essential for repairing and stabilizing heart valves, addressing conditions such as regurgitation and stenosis, and improving patient outcomes. The rising impact of CVD makes annuloplasty systems a critical component of cardiac care. Moreover, heart disease remains the leading cause of death in the U.S., affecting individuals across genders and backgrounds. According to a CDC report published in October 2024, a cardiovascular-related death occurs every 33 seconds, highlighting the urgent need for advanced medical devices to prevent, diagnose, and treat heart conditions effectively. This critical demand extends to treating heart valve disorders, where annuloplasty systems are essential in restoring valve function and improving patient outcomes. The rising prevalence of heart disease drives the market for innovative annuloplasty solutions to address this growing healthcare challenge.

The increasing prevalence of heart valve diseases has led several governments and private organizations to take the initiative and conduct programs to spread awareness about heart valve diseases. For instance, in February 2024, the Centre for Valvular Heart Disease (CVHD) hosted a mobile screening program at the University of Ottawa Heart Institute (UOHI) to offer free heart valve and cardiovascular risk factors screening. Such initiatives by government and private organizations to increase awareness about heart valve diseases and promote the diagnosis of these diseases are expected to drive market growth over the forecast period.

Similarly, the global population is aging, with several countries such as Japan, Italy, and others facing significantly higher risks of an aging population. According to the WHO, the population base aged 60 years or above is expected to more than double to reach 2.1 billion in 2050, increasing from 1 billion in 2020. This population base poses a significant risk of developing cardiovascular diseases over the period. Cardiovascular diseases such as mitral valve regurgitation and tricuspid valve insufficiency may require annuloplasty procedures to restore cardiac function and address valvular defects, which is expected to drive the demand for annuloplasty systems and drive the market growth over the forecast period.

The increasing incidence of CHD drives the growth of the market. According to the British Heart Foundation article published in September 2024, with over 250 million people worldwide living with coronary heart disease (CHD), the prevalence of this condition is driving the need for effective treatment solutions. CHD often leads to heart valve issues, making annuloplasty systems crucial in managing and restoring heart valve function. As the global population ages and the burden of CHD grows, minimally invasive treatments such as annuloplasty offer a promising solution for improving patient outcomes and addressing the rising demand for cardiovascular care.

Global Annuloplasty System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global annuloplasty system market report based on application, end use, and region:

• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Mitral Valve Repair
• Tricuspid Valve Repair
• Aortic Valve Repair
• End Use Outlook (Revenue, USD Million, 2018 - 2030-2030)
• Hospitals
• Ambulatory Surgical Centers
• Others
• Regional Outlook (Revenue, USD Million, 2018-2030)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.